Nateglinide antidiabetic drugs
systematic review meta-analysis network meta-analysis

Fastic - A-4166 - A 4166 - Novartis brand of nateglinide - Starlix - Starsis - DJN 608 - AY-4166 - AY 4166 - IPCCPA - senaglinide - nate-glinide - nateglinide

Select pdf

Filter

Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	Diabetes	normoglycemia
Group by... in first in second in third	Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Global trial result Main results All results All result tag NCT results	Numeric bar chart forest plot medians
diabetes type 2
NAVIGATOR nateglinide, 2010 NCT	nateglinide	placebo			Low risk of bias	negative
Marre, 2002	nateglinide	placebo			Low risk of bias	-
Horton, 2000	nateglinide	placebo			Low risk of bias	-
Hanefeld, 1990	nateglinide	placebo			Low risk of bias	-
Saloranta, 2002	nateglinide	placebo			Low risk of bias	-
Mari, 2005	nateglinide	placebo				-
Moses, 2001	nateglinide	placebo			Low risk of bias	-
Goldberg, 1998	repaglinide	placebo			Low risk of bias	-
Jovanovic, 2000	repaglinide	placebo			Low risk of bias	-
Bech, 2003	repaglinide	placebo			Low risk of bias	-
Li, 2009	nateglinide	repaglinide				-
Li, 2007	nateglinide	repaglinide				-
Ristic, 2006	nateglinide	gliclazide (add on MET)			Low risk of bias	-
impaired fasting glucose
NAVIGATOR nateglinide, 2010 NCT	nateglinide	placebo			Low risk of bias	negative